Position in PBYI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,247,282
+$689,229 QoQ
Shares Held
508,182
+18.2% QoQ
Ownership
0.998%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $1,278,895,108 across 195 Biotechnology names. PBYI ranks #44 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,395,794 | $228,240,234 | |
| 2 | ARGX |
Argenx SE
|
286,966 | $209,556,920 | |
| 3 | ASND |
Ascendis Pharma A/S
|
351,146 | $80,317,623 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,629,670 | $69,896,545 | |
| 5 | INCY |
Incyte Corp
|
714,558 | $67,254,197 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,226 | $59,490,737 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
75,000 | $57,947,999 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
100,315 | $33,191,223 |
All Filings in PBYI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,247,282 | 508,182 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,558,053 | 429,925 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,843,811 | 347,234 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,191,012 | 347,234 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,029,129 | 347,679 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $950,565 | 311,661 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $735,628 | 288,482 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $943,890 | 289,537 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,535,287 | 289,677 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,263,787 | 291,868 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $751,277 | 285,657 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,008,160 | 285,598 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $883,925 | 286,060 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,210,477 | 286,165 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $676,044 | 285,251 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $809,228 | 283,940 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $822,567 | 285,614 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $863,581 | 284,073 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,906,179 | 271,923 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,099,539 | 228,708 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,483,573 | 152,631 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,571,134 | 153,132 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,800,136 | 178,408 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $1,566,335 | 150,176 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,260,462 | 149,344 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||